When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association task force on risk reduction

Scott M. Grundy*, Gary J. Balady, Michael H. Criqui, Gerald Fletcher, Philip Greenland, Loren F. Hiratzka, Nancy Houston-Miller, Penny Kris-Etherton, Harlan M. Krumholz, John LaRosa, Ira S. Ockene, Thomas A. Pearson, James Reed, Sidney C. Smith, Reginald Washington

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

137 Scopus citations
Original languageEnglish (US)
Pages (from-to)1683-1685
Number of pages3
JournalCirculation
Volume95
Issue number6
DOIs
StatePublished - 1997

Keywords

  • AHA Medical/Scientific Statements
  • cholesterol
  • diet
  • drugs
  • prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this